Cohera completes $25M raise, looks to donduct U.S. clinical trials
Cohera closed its $25M series C finaning round, which begain in spring 2010 with $16.5 million in convertible notes from existing investors, as well as $9.2 M from new investors this year.
Read more in the Pittsburgh Business Times
